Insider · CIK 0001643085

GANNON STEVEN

Reports to the SEC for 2 companies · BURNABY

sec.gov

Transactions

Companies

Filings

CIK

0001643085

Forms 4 and 5

Insider transactions

44 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-11	XENEXenon Pharmaceuticals Inc.S Sale	Director	SSale	−10K sh	$64.06	−$641K	1,870
2026-06-03	XENEXenon Pharmaceuticals Inc. · Share Option (Right to Buy)A Award	Director	AAward	+10.5K sh	—	—	10,507
2026-06-03	XENEXenon Pharmaceuticals Inc. · Restricted Share UnitsA Award	Director	AAward	+1,593 sh	—	—	1,593
2026-06-01	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,645 sh	—	—	13,286
2026-06-01	XENEXenon Pharmaceuticals Inc.F Tax Payment	Director	FTax Payment	−1,416 sh	$53.41	−$75.6K	11,870
2026-06-01	XENEXenon Pharmaceuticals Inc. · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,645 sh	—	—	0
2026-05-12	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,500 sh	$7.38	+$25.8K	10,641
2026-05-12	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,500 sh	—	—	0
2025-06-05	XENEXenon Pharmaceuticals Inc.S Sale	Director	SSale	−3 sh	$30.48	−$91.44	7,141
2025-06-05	XENEXenon Pharmaceuticals Inc. · Share Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,012
2025-06-05	XENEXenon Pharmaceuticals Inc. · Restricted Share UnitsA Award	Director	AAward	+2,645 sh	—	—	2,645
2025-05-14	XENEXenon Pharmaceuticals Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,144 sh	$12.57	+$64.7K	7,144
2025-05-14	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,144 sh	—	—	0
2024-06-05	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15.5K sh	—	—	15,542
2024-06-04	Fusion Pharmaceuticals Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−56.4K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−141K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17K sh	—	—	0
2024-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17K sh	—	—	0
2024-03-07	XENEXenon Pharmaceuticals Inc.S Sale	Director	SSale	−1,000 sh	$46.45	−$46.5K	14,000
2024-03-07	XENEXenon Pharmaceuticals Inc.S Sale	Director	SSale	−5,000 sh	$46.25	−$231K	9,000
2024-03-07	XENEXenon Pharmaceuticals Inc.S Sale	Director	SSale	−5,000 sh	$46.30	−$232K	4,000
2024-03-07	XENEXenon Pharmaceuticals Inc.S Sale	Director	SSale	−2,000 sh	$46.20	−$92.4K	2,000
2023-06-14	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,000
2023-06-02	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.5K sh	—	—	18,475
2022-08-11	Fusion Pharmaceuticals Inc.P Purchase	Director	PPurchase	+44.4K sh	$2.03	+$90.1K	56,400
2022-06-28	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000
2022-06-14	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,000
2021-08-23	Fusion Pharmaceuticals Inc.P Purchase	Director	PPurchase	+2,829 sh	$7.99	+$22.6K	12,000
2021-08-19	Fusion Pharmaceuticals Inc.P Purchase	Director	PPurchase	+3,000 sh	$8.05	+$24.2K	9,171
2021-08-18	Fusion Pharmaceuticals Inc.P Purchase	Director	PPurchase	+171 sh	$8.05	+$1,376.55	6,171
2021-08-16	Fusion Pharmaceuticals Inc.P Purchase	Director	PPurchase	+6,000 sh	$8.10	+$48.6K	6,000
2021-06-04	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,000
2021-06-03	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-06-25	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2020-06-01	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-01-19	Fusion Pharmaceuticals Inc.Stock Option (Right to Buy)A Award	Director	AAward	+141K sh	—	—	141,011
2019-09-16	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2018-06-04	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2017-08-11	XENEXenon Pharmaceuticals Inc.P Purchase	Director	PPurchase	+15K sh	$2.82	+$42.3K	15,000
2017-06-01	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,500 sh	—	—	3,500
2016-06-02	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,500 sh	—	—	3,500
2015-05-21	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,144 sh	—	—	5,144

Recent filings

Accepted (ET)
Aug 134
GANNON STEVEN0001193125-26-349351
SEC(opens sec.gov)
Jun 34
GANNON STEVEN0001193125-26-256121
SEC(opens sec.gov)
May 134
GANNON STEVEN0001193125-26-222369
SEC(opens sec.gov)
Jun 64
GANNON STEVEN0000950170-25-083321
SEC(opens sec.gov)
May 164
GANNON STEVEN0000950170-25-073746
SEC(opens sec.gov)
Jun 54
GANNON STEVEN0000950170-24-069464
SEC(opens sec.gov)
Jun 44
GANNON STEVEN0000950170-24-068906
SEC(opens sec.gov)

Companies

Address

3650 GILMORE WAY

BURNABY, V5G 4W8